Daily low dose aspirin does not significantly reduce the risk of colorectal cancer, according to a large analysis of previous ...

“Aspirin is a drug that is readily available globally and extremely inexpensive compared to many modern cancer drugs, which ...

An inexpensive, common pill sitting in millions of medicine cabinets may be doing far more than easing headaches. Aspirin ...

Long-term trials show aspirin may cut colon cancer risk by 50% in people with Lynch syndrome, a genetic condition that heightens cancer susceptibility. The findings, led by Professor John Burn, are ...

Research in mice shows how aspirin may boost the immune response against cancer, keeping secondary tumors at bay. Image credit: AsiaVision/Getty Images. According to Cancer Research UK, half of all ...

New research has found that aspirin use can cut colon cancer cases by half among people with Lynch syndrome, a genetic condition that increases cancer risk. The findings, from long-term trials, have ...

One of aspirin’s most intriguing properties is its anti-cancer activity. A Swedish research study published in the New England Journal of Medicine (Sept. 18, 2025) concludes that aspirin can ...

Recent research from Massachusetts General Hospital and Harvard Medical School has uncovered aspirin‘s surprising protective effect against colorectal cancer, particularly among individuals with less ...

The hypothesis that low-dose aspirin might eventually lower cancer risk after years of use appears unsupported in adults aged 70 years or older, according to new long-term data from the ASPREE trial.

Aspirin is often touted as the wonder drug of the 20th century. Famous for its versatility—easing aches and pains, reducing fever and inflammation, preventing heart attacks and stroke—experts have ...